FDA - "Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Products Manufacturing"

Title: Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Products Manufacturing Source: FDA Data/Action: Guidance Date: 6/19/2020 Text Preview: ...(COVID-19) (https://www.cdc.gov/coronavirus/2019ncov/community/guidance-business-response.html) • EPA web page List N: Disinfectants for Use Against...